Vitamin D in ankylosing spondylitis: Review and meta-analysis

Clinica Chimica Acta

Volumn 438, Issue , 2015, Pages 316-322

  Cai, Guoqi ^a   Wang, Li ^a   Fan, Dazhi ^a   Xin, Lihong ^a   Liu, Li ^a   Hu, Yanting ^a   Ding, Ning ^a   Xu, Shengqian ^a   Xia, Guo ^a   Jin, Xingzhong ^b   Xu, Jianhua ^a   Zou, Yanfeng ^a   Pan, Faming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Alkaline phosphatase; Ankylosing spondylitis; Disease activity; Meta analysis; Serum vitamin D; Systemic inflammation

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D; CALCIFEDIOL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANKYLOSING SPONDYLITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CALCIUM BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; META ANALYSIS; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

ALKALINE PHOSPHATASE; C-REACTIVE PROTEIN; CALCIFEDIOL; CALCITRIOL; CALCIUM; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; HUMANS; PARATHYROID HORMONE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84907487306     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.08.040     Document Type: Review

References (56)

1. Dougados M., Baeten D. Spondyloarthritis. Lancet 2011, 377:2127-2137.
2. Reveille J.D. The genetic basis of spondyloarthritis. Ann. Rheum. Dis. 2011, 70(Suppl. 1):i44-i50.
3. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
4. Australo-Anglo-American Spondyloarthritis Consortium, Reveille J.D., Sims A.M., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 2010, 42:123-127.
5. Fischer R., Trudgian D.C., Wright C., et al. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol. Cell. Proteomics 2012, 11. (M111.013904).
6. Kamen D., Aranow C. Vitamin D in systemic lupus erythematosus. Curr. Opin. Rheumatol. 2008, 20:532-537.
7. Perez-Lopez F.R. Vitamin D, and its implications for musculoskeletal health in women: an update. Maturitas 2007, 58:117-137.
8. Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann. Rheum. Dis. 2009, 68:446-447.
9. Mohammadnejad Z., Ghanbari M., Ganjali R., et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol. Biol. Rep. 2012, 39:831-837.
10. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
11. Gatenby P., Lucas R., Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Curr. Opin. Rheumatol. 2013, 25:184-191.
12. Muller K., Kriegbaum N.J., Baslund B., Sorensen O.H., Thymann M., Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin. Rheumatol. 1995, 14:397-400.
13. Braun-Moscovici Y., Toledano K., Markovits D., Rozin A., Nahir A.M., Balbir-Gurman A. Vitamin D level: is it related to disease activity in inflammatory joint disease?. Rheumatol. Int. 2009, 31:493-499.
14. Arends S., Spoorenberg A., Bruyn G.A.W., et al. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos. Int. 2010, 22:1431-1439.
15. Lange U., Jung O., Teichmann J., Neeck G. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos. Int. 2001, 12:1031-1035.
16. Mermerci Baskan B., Pekin Dogan Y., Sivas F., Bodur H., Ozoran K. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol. Int. 2010, 30:375-381.
17. Lange U., Teichmann J., Strunk J., Muller-Ladner U., Schmidt K.L. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos. Int. 2005, 16:1999-2004.
18. Franck H., Keck E. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann. Rheum. Dis. 1993, 52:343-346.
19. You-yu L., Jie C., Yi Z., Yi L. Clinical significance of vitamin D and vitamin D receptor in patients with ankylosing spondylitis. New Chin. Med. 2011, 3:192-196.
20. Hmamouchi I., Allali F., El Handaoui B., et al. The relation between disease activity, vitamin D levels and bone mineral density in men patients with ankylosing spondylitis. Rheumatol. Rep. 2013, 5.
21. Moll J.M., Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann. Rheum. Dis. 1973, 32:354-363.
22. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute http://wwwohrica/programs/clinical_epidemiology/oxford.
23. Zhu Z.H., Jin X.Z., Zhang W., et al. Associations between vitamin D receptor gene polymorphisms and osteoarthritis: an updated meta-analysis. Rheumatology (Oxford) February 4 2014, (published online first). 10.1093/rheumatology/ket418.
24. Jin X., Beguerie J.R., Zhang W., et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 2013, 1-8.
25. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
26. Smith G.D., Egger M. Meta-analysis of randomised controlled trials. Lancet 1997, 350:1182.
27. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
28. Durmus B., Altay Z., Baysal O., Ersoy Y. Does vitamin D affect disease severity in patients with ankylosing spondylitis?. Chin. Med. J. (Engl.) 2012, 125:2511-2515.
29. Yazmalar L., Ediz L., Alpayci M., Hiz O., Toprak M., Tekeoglu I. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Afr. Health Sci. 2013, 13:47-55.
30. Singh H.J., Nimarpreet K., Ashima, Das S., Kumar A., Prakash S. Study of bone mineral density in patients with ankylosing spondylitis. J. Clin. Diagn. Res. 2013, 7:2832-2835.
31. Gratacos J., Collado A., Pons F., et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999, 42:2319-2324.
32. Cantorna M.T. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 2012, 523:103-106.
33. Cao Y., Winzenberg T., Nguo K., Lin J., Jones G., Ding C. Association between serum levels of 25-hydroxyvitamin D and osteoarthritis: a systematic review. Rheumatology 2013, 52:1323-1334.
34. Bikle D.D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014, 21(3):319-329. (Epub 2014 Feb 13). 10.1016/j.chembiol.2013.12.016.
35. Klingberg E., Lorentzon M., Gothlin J., et al. Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes. Arthritis Res. Ther. 2013, 15:R179.
36. Magrey M., Khan M.A. Osteoporosis in ankylosing spondylitis. Curr. Rheumatol. Rep. 2010, 12:332-336.
37. Cantatore F.P., Corrado A., Grano M., Quarta L., Colucci S., Melillo N. Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clin. Rheumatol. 2004, 23:490-495.
38. Kriegel M.A., Manson J.E., Costenbader K.H. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin. Arthritis Rheum. 2011, 40. (512-531 e518).
39. Bosse Y., Lemire M., Poon A.H., et al. Asthma and genes encoding components of the vitamin D pathway. Respir. Res. 2009, 10:98.
40. Matsuyama T., Ishii S., Tokita A., et al. Vitamin D receptor genotypes and bone mineral density. Lancet 1995, 345:1238-1239.
41. Morrison N.A., Qi J.C., Tokita A., et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
42. Bikle D.D. What is new in vitamin D: 2006-2007. Curr. Opin. Rheumatol. 2007, 19:383-388.
43. Overbergh L., Decallonne B., Valckx D., et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 2000, 120:139-146.
44. Baeten D., Kruithof E., Van den Bosch F., et al. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum. 2001, 44:186-195.
45. Schacht E. Osteoporosis in rheumatoid arthritis-significance of alfacalcidol in prevention and therapy. Z. Rheumatol. 2000, 59(Suppl. 1):10-20.
46. Shany S., Levy Y., Lahav-Cohen M. The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 2001, 66:319-325.
47. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 2006, 81:353-373.
48. Saliba W., Barnett O., Rennert H.S., Lavi I., Rennert G. The relationship between serum 25(OH)D and parathyroid hormone levels. Am. J. Med. 2011, 124:1165-1170.
49. Okazaki R., Sugimoto T., Kaji H., et al. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D(3) load in Japanese subjects. J. Bone Miner. Metab. 2011, 29:103-110.
50. van Straalen J.P., Sanders E., Prummel M.F., Sanders G.T. Bone-alkaline phosphatase as indicator of bone formation. Clin. Chim. Acta 1991, 201:27-33.
51. Baek H.J., Kang S.W., Lee Y.J., et al. Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol. Int. 2005, 26:30-34.
52. Vasudevan J., Jenifer A., Reddy G.M., Thayumanavan S. Serum alkaline phosphatase for screening of hypovitaminosis D. Indian Pediatr. 2014, 51:60-61.
53. McVeigh C.M., Cairns A.P. Diagnosis and management of ankylosing spondylitis. BMJ 2006, 333:581-585.
54. Ruof J., Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J. Rheumatol. 1999, 26:966-970.
55. Garrett S., Jenkinson T., Kennedy L.G., Whitelock H., Gaisford P., Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J. Rheumatol. 1994, 21:2286-2291.
56. Zhao S., Duffield S.J., Moots R.J., Goodson N.J. Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. Rheumatology (Oxford) April 4 2014, (published online first). 10.1093/rheumatology/k.